The Effects of Fasting and Massive Diarrhea on Absorption of Enteral Vancomycin in Critically Ill Patients: A Retrospective Observational Study
PurposeAlthough vancomycin (VCM) is not absorbed from healthy intestinal mucosa, elevations in the serum VCM concentrations have been reported in some cases. The aims of this study are to evaluate the necessity of therapeutic drug monitoring (TDM) during enteral VCM administration in critically ill...
Main Authors: | Takehiko Oami, Noriyuki Hattori, Yosuke Matsumura, Eizo Watanabe, Ryuzo Abe, Taku Oshima, Waka Takahashi, Shingo Yamazaki, Tatsuya Suzuki, Shigeto Oda |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-06-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fmed.2017.00070/full |
Similar Items
-
Gut colonization with vancomycin-resistant Enterococcus and risk for subsequent enteric infection
by: Jordan E. Axelrad, et al.
Published: (2018-07-01) -
Étude de la cinétique fécale de la vancomycine suite à son administration orale pour une suspicion d'une infection à Clostridium difficile (ICD)
by: Gonzales Fuertes, Milagros
Published: (2010) -
Rash induced by enteral vancomycin therapy in an older patient in a long-term care ventilator unit: case report and review of the literature
by: Jeremy Barron, et al.
Published: (2018-11-01) -
Detection of vancomycin-resistant enterococci (VRE) in stool specimens submitted for Clostridium difficile toxin testing
by: Sevim Özsoy, et al. -
Prolonged oral vancomycin for secondary prophylaxis of relapsing Clostridium difficile infection
by: Kevin Zhang, et al.
Published: (2019-01-01)